A three year prospective, double blinded, placebo controlled, randomized clinical trial in
impaired glucose tolerance (IGT) subjects to study the effect of pioglitazone in preventing
the conversion to Diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
M.V. Hospital for Diabetes
Collaborator:
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals